Who we are, What we do

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Who we are

Corporate Introduction

The Kyowa Hakko Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.

Commitment to Life

“Commitment to Life” is the mission statement of Kyowa Hakko Kirin. The statement expresses the strong determination of each employee to devote themselves to saving the lives of all who are suffering from diseases through the development of new drugs.

What we do

Road Map to Our Vision

FY2016-2020 Mid-term Business Plan
“Leaping forward for Global Specialty Pharmaceutical Company(GSP)”

In order to realize the vision of becoming a global specialty pharmaceutical company(GSP) from Japan, the Kyowa Hakko Kirin Group has promoted the selection and concentration of businesses since 2008 and has constructed a globally unique business base. Under the FY2016-2020 Mid term Business Plan, “Leaping forward for Global Specialty Pharmaceutical Company(GSP)”,we aim to further strengthen and expand that base and to become a Japan based world-leading R&D type life science company.

Road Map to Our Vision

Being a 'Japan-based world-leading R&D type life science company' STEP1:2008-2009 Integrate Strength, STEP2:2010-2012 Select and Concentrate, STEP3:2013-2015 Strive toward GSP, STEP4:2016-2020 Leaping forward for GSP, Improvement of Global Competitiveness / Creating Innovation / Continuous Improvement for Operational Excellence / Contribution to Health and Well-being of People. Core Operating Profit: over 100 billion JPY, Overseas Sales: 50%, ROE: over 10%

* Operating Income + Amortization of goodwill + Share of profit/loss of entitles accounted for using equity method

For Your Information

To Page Top